Aequs Ltd. Share Price

Overview

Aequs Ltd. share price is currently ₹238.90, down by - ₹6.20 (2.53%) from its previous closing price of ₹245.10. The share price has gained 3.89% over the past month and gained 0% over the past year. The stock's 52-week low and high are ₹111.97 and ₹292.72, respectively. Aequs Ltd. has a market capitalisation of ₹ 17,190.00 Cr. The share price was last updated on 22 Oct 2026, 10:16 AM IST.

Aequs Ltd.
Aequs Ltd.
AEQUS
 ₹0.00
- ₹6.20
2.53%
Capital Goods
 ₹0.00(%)1D

Updated: 22 Oct 2026, 10:16:51 am IST

Market Data

Open Price

 ₹243.78

Prev. Close

 ₹245.10
 ₹235.89

Day Low

 ₹244.27

Day High

 ₹111.97

52 Week Low

 ₹292.72

52 Week High

Capital GoodsDefence
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

-141.36

Sector PE

46.20

PB Ratio

10.84

Sector PB

8.22

EPS

-1.69

Dividend Yield

0.00

Today's Volume

633.385 K

5 Day Avg. Volume

2.705 M

PEG Ratio

-35.34

Market Cap.

₹ 17,190.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
SBI Children's Fund - Investment Plan - Regular Plan - Growth1.00 Cr
1.00 Cr
no change
SBI MNC Fund - Regular Plan - IDCW20.00 Lac
27.25 Lac
(36.23%)
Motilal Oswal Nifty India Defence Index Fund - Regular Plan - Growth15.79 Lac
22.26 Lac
(41.01%)
HDFC Manufacturing Fund - Regular Plan - Growth17.77 Lac
17.77 Lac
no change
Qsif Equity Ex-Top 100 Long-Short Fund - Regular Plan - Growth-
15.44 Lac
(100%)

About Aequs Ltd. 👋

Aequs Limited, formerly Aequs Private Limited, is an India-based diversified contract manufacturing company. The Company provides vertically integrated product solutions across the aerospace and consumer goods industries. It focuses on precision machining for AeroSystems, aerostructures, landing gear and engine components, sheet metal fabrication, forging, surface treatment, aerostructure assembly and testing and prototyping components for original equipment manufacturers across the globe. Its aerospace portfolio includes forging, precision machining, surface treatment, and aerostructure assembly. Its consumer goods are engaged in the manufacture of plastic, metallic and electronic consumer goods. Its product portfolio includes consumer electronics, digital healthcare devices and plastics, and consumer durables. Its diverse consumer product portfolio includes consumer durables such as cookware and small home appliances, and components such as portable computers and smart devices.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Ishwar Kathed

Ishwar Kathed

13 Oct • 12:32 PM · SEBI-Registered Analyst

Aequs signs long-term aerospace supply deals with Safran

Aequs has signed long-term supply agreements with Safran, a global aerospace industry leader, to manufacture critical components for commercial aircraft programmes. Key highlights Expanded partnership: The agreements extend Aequs’ existing relationship with Safran Landing Systems to Safran Aerosystems. Aircraft programmes: Components will support Airbus A320, A330 and A350, and Boeing 787 programmes. Manufacturing scope: Contracts cover superalloy machining, complex machining, coating and assembly of landing gear components. Production capabilities: Aequs will use its integrated aerospace manufacturing ecosystem at the Belagavi Aerospace Cluster. Future expansion: The upcoming Aequs Engine Components Ecosystem in Hosur, Tamil Nadu, is expected to expand its manufacturing capabilities. Why it matters: The agreements broaden Aequs’ engagement with a major global aerospace supplier and strengthen its position in precision-engineered aircraft components. Long-term supply arrangements may improve business visibility, but the company has not disclosed the contract value or expected revenue contribution in the information provided. What to watch next: Contract execution, production volumes, capacity utilisation, margins and the financial contribution from the expanded Safran relationship. Learning outcome: Long-term aerospace supply agreements can strengthen customer relationships and manufacturing visibility, but investors should assess contract value, execution requirements and profitability before estimating their financial impact.

See More
Pyrifera Investment Advisors

Pyrifera Investment Advisors

13 Oct • 1:52 AM · SEBI-Registered Analyst

Aequs signs multi-year Safran aerospace contracts

Aequs signed multi-year supply agreements with Safran to manufacture critical aerospace assemblies. This expands its aerospace order book beyond $1 billion, supporting a 55% YoY Q1 FY27 revenue surge to ₹395.5 crore. The contracts cover superalloy machining and landing gear component assembly for Airbus and Boeing programs, leveraging the Belagavi aerospace cluster. This matters because it transitions Aequs from basic machining to high-value, flight-critical sub-assemblies, locking in long-term Tier-1 integration. I am watching the Q3 FY27 earnings call for the specific revenue realization from these Safran contracts and the capacity utilization rate of the Belagavi facility. The market prices Aequs purely on its current order book momentum, viewing it as a standard contract manufacturing play. What the consensus misses is the structural margin expansion from this specific scope upgrade. Step one: superalloy machining commands significantly higher pricing power and barriers to entry than standard aluminum parts. Step two: landing gear sub-assemblies increase the realization per aircraft, capturing more value from the same production cycle. Step three: multi-year agreements with a dominant Tier-1 like Safran de-risk revenue visibility against global OEM delivery fluctuations. The market misprices this as routine order flow, ignoring that it mechanically elevates the company's return on capital employed (ROCE) through a premium product mix. Accumulate for long-term margin and order book expansion. Disclosure: I do not hold positions in this stock. This is for educational purposes only and does not constitute investment advice.

AEQUS

See More
RAJIV GUPTA (SEBI RA)

RAJIV GUPTA (SEBI RA)

12 Oct • 5:49 PM · SEBI-Registered Analyst

Aequs Announces Long-Term Supply Agreements

AEQUS
Aequs Ltd today announced the signing of long-term supply agreements with Safran, a global leader in the aerospace industry for critical components. These agreements reflect the commitment of both companies to strengthen their collaboration and highlight Safran's dedication to working with trusted, high-quality industrial partners. The contracts will support Safran's supply chain and ongoing production programs, while also contributing to the growth and development of Aequs within the aerospace sector. This milestone represents a significant opportunity for Aequs to further expand its activities alongside one of the world's leading aerospace companies. Opinion : This news will have positive impact on the stock price. Disclaimer : This is not buy,sell or hold recommendation

See More
Tejaswi

Tejaswi

5 Oct • 9:02 AM · SEBI-Registered Analyst

Aequs: $1 billion order book, four straight years of losses

AEQUS
Aequs Limited (NSE: AEQUS) grew Q1 FY27 consolidated revenue 55% to ₹395.5 crore. Aerospace, at 81% of revenue, grew 40% to ₹322.2 crore. The stock is up 96% since its December 2025 listing and trades at 12.4 times book value. What happened Aerospace EBITDA rose 35% to ₹73.1 crore, though it was below the ₹101 crore in Q4 FY26. Utilisation was 70% globally and 78% in India. The aerospace order book crossed $1 billion, rising 13% QoQ from $889 million. Aequs signed two new aerostructures Tier-1 agreements and won its first contract to manufacture Airbus A320 wheels for Safran Landing Systems under a 15-year sole-source deal. Why it matters The order book change matters. The portfolio now has 5,740 qualified products, with 86 added in Q1 alone. The top three customer groups have an average relationship of 15 years. My view Four consecutive years of losses: ₹(110), ₹(14), ₹(102) and ₹(113) crore. Operating profit is positive. Interest, depreciation and other costs consume it. IPO proceeds cut net debt to equity to 0.34 times from 0.88 times. But operating cash flow turned negative at ₹41.4 crore as working capital expanded. Full year FY27 capex is ₹660 crore, including ₹160 crore for aerospace. The Hosur ecosystem needs ₹1,900 crore over 10 years, with revenue from FY29. JM Financial downgraded to Reduce in May 2026 with a ₹210 target. The stock closed at ₹275, about 31% above that. What I am watching Q2 FY27 results, operating cash flow turning positive, and the first consolidated profit. On the chart, ₹200 is the IPO listing area and the key support. My stance: Wait for one profitable quarter. The order book is real. The profits are not yet there. Disclosure: I do not hold a position in Aequs Limited at the time of writing. This is not investment advice.

See More
ArthavrkshRA

ArthavrkshRA

28 Sep • 11:15 PM · SEBI-Registered Analyst

Aequs Jumps around 6% on Capex News, Tests Range High

AEQUS
closed at 260.10, up 5.71%, after the precision engineering and contract manufacturing company outlined a Rs 660 crore capex budget for FY27, aimed at expanding its aerospace and consumer businesses. As per a Moneycontrol report, the company's board has separately approved a Rs 650 crore equity infusion through warrants issued to the promoter group, with 50% payable upfront on allotment, and another fundraise is anticipated in FY28 to sustain the growth push. On the chart, this move has taken price right up to the descending trendline resistance near 270-274 that has capped rallies since July, after the stock found support multiple times near the 215 zone over the past few months. RSI at 68.04, above the signal line at 45.05, reflects the strength of today's move, with volume also picking up sharply on the breakout attempt. Resistance: 270-274 (descending trendline), then 280 (prior swing high). Support: 246-252 (near-term), then 215 (range low). Whether today's capex-driven move is enough to close above the trendline on a sustained basis, or whether the stock fades back into the recent range, is what needs to be watched over the coming sessions. A strong fundamental trigger testing a well-defined trendline resistance is a useful setup to track — the follow-through, not the news itself, confirms the technical outcome. Disclaimer:This is for educational purposes only and is not investment advice. Please consult your financial advisor before making any investment decisions. SEBI Registered Research Analyst — INH000025212.

See More
Adarsh Nimborkar (SEBI IA)

Adarsh Nimborkar (SEBI IA)

28 Sep • 9:38 PM · SEBI-Registered Analyst

Aequs Ltd Engineering Company Fundamental Analysis

AEQUS
Aequs is an engineering-led, vertically integrated contract manufacturing company with a strong presence in aerospace and an emerging consumer manufacturing business. Its aerospace ecosystem covers precision components, machining, forging, surface treatment and assemblies, allowing the company to serve global OEMs and Tier-1 suppliers through an integrated manufacturing model. The consumer segment is being scaled across consumer electronics and other products, creating an additional long-term growth avenue. FY26 revenue increased 33% YoY to ₹1,230.4 crore and EBITDA rose 43% to ₹154.5 crore, with EBITDA margin improving to 13%. However, the company remained loss-making, reporting a consolidated PAT loss of ₹113.3 crore for FY26. Q1 FY27 revenue increased a strong 54.8% YoY to ₹395.5 crore, but net loss remained high at ₹53.2 crore. Aerospace revenue grew 39.9% to ₹322.2 crore and generated a segment profit of ₹73.1 crore, while consumer revenue surged 190.4% to ₹73.4 crore but recorded a ₹36.1 crore segment loss. The major growth drivers are increasing aerospace outsourcing, new programs with global customers, capacity utilisation and the ramp-up of consumer manufacturing. The IPO has also substantially strengthened the balance sheet; FY26 debt-equity declined to around 0.23x and net worth increased sharply. However, the current valuation requires close attention: Groww reports a market capitalisation of about ₹16,287 crore, negative TTM earnings, P/B around 10.96x and ROE of -7.41%. The key risks are continued consolidated losses, high depreciation and finance costs, execution risk in new consumer facilities, working-capital requirements and the substantial valuation relative to present earnings. The central factor to monitor is whether strong aerospace growth and consumer scale-up can eventually translate into sustainable consolidated profitability.

See More

News & Events

Frequently Asked Questions

What is the share price of Aequs Ltd.?

What is the market cap of Aequs Ltd.?

Should I buy Aequs Ltd. stock now?

What is the 52 week high and low of Aequs Ltd.?

Is the Aequs Ltd. stock good to buy?

Is Aequs Ltd. a good buy for the long term?

Is Aequs Ltd. overvalued or undervalued?

What is the PE and PB ratio of Aequs Ltd.?

Start Now